Draft genomes of an multi-drug resistant Klebsiella pneumoniae strain KP110, isolated from patient in
Klebsiella pneumoniae (KPN) serves as a major opportunistic pathogen causing infections in immunocompromised individuals. The rising prevalence of clinical isolates displaying multidrug-resistant (MDR) and pan-drug-resistant (PDR) phenotypes poses a significant challenge to clinical treatment. In this study, we characterized a clinical KPN isolate, KP110, obtained from a patient in Dalian, China. This finding provides new insights into the co-evolution of antimicrobial resistance and hypervirulence in K. pneumoniae.